UNSPSC 85892561: High dose rate (hdr) brachytherapy of left breast using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of left breast using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DM109BZ

UNSPSC 85892561 High dose rate (hdr) brachytherapy of left breast using palladium 103 (pd-103) is a Commodity code that shows no relevant recent state and local procurement activity. The single recent opportunity posted under this code—the County of Santa Clara Health System's July 2026 solicitation for temporary health professional staffing services across ancillary clinical categories (Audiology, Cardiology, Diagnostic Imaging, Gastroenterology, Orthopedic, Respiratory Care, Sterile Processing, Surgical/Operating Room, and related roles)—is unrelated to the code's nominal scope of specialized radiation oncology treatment. The staffing solicitation does not involve procurement of brachytherapy equipment, radiation sources, clinical protocols, or medical devices.

No state or local jurisdictions have posted procurement activity matching the code's intended scope of high-dose-rate palladium-103 brachytherapy services or related equipment and supplies in the recent opportunities tracked by this source. A business development professional evaluating this code should treat it as inactive in state and local markets and investigate whether the code has been misapplied by procurement offices or whether demand for this specialized oncology service delivery exists through other procurement channels—such as hospital system capital equipment RFPs, cooperative purchasing vehicles, or integrated health-system contracts that may be tagged at higher-tier Family or Class levels rather than at this narrowly defined Commodity tier.